Basic information
- CAS
72131-33-0- Standard SMILES
O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1- InChIKey
XTNWJMVJVSGKLR-UHFFFAOYSA-N- Molecular formula
- C16H17NO5S
- Average molar mass
- 335.4 g/mol
- Monoisotopic mass
- 335.08274382
Overview
Sulotroban is a small molecule drug. Sulotroban has a monoisotopic molecular weight of 335.08 Da.
Names & identifiers
- Preferred name
- Sulotroban
- IUPAC
- 2-[4-[2-(benzenesulfonamido)ethyl]phenoxy]acetic acid
- English name
- Sulotroban
- Molecular formula
- C16H17NO5S
- Molecular weight
- 335.37
Names & synonyms
SULOTROBAN72131-33-0BM-13177SKF-95587SulotrobanumSK&F 95587BM 13.177SK&F-95587SKF 95587Acetic acid, (4-(2-((phenylsulfonyl)amino)ethyl)phenoxy)-(p-(2-Benzenesulfonamidoethyl)phenoxy)acetic acidSKF95587
Show more names
Sulotraban4-[2-[(Phenylsulfonyl)amino]ethyl]phenoxyacetic acidAcetic acid, 2-[4-[2-[(phenylsulfonyl)aMino]ethyl]phenoxy]-
4-(2-(benzenesulfonamido)ethyl)phenoxyacetic acid74574CO5A6BM13177BM-13.177DTXSID80222440RefChem:932400DTXCID80144931BM 13177
Database identifiers
- CAS
72131-33-0- PubChem CID
- 51550
- DTXSID
DTXSID80222440- ChEMBL
CHEMBL8273- UNII
- 74574CO5A6
- Nikkaji
- J21.727A
Properties
Computed structural properties
- XLogP
- 2.4
- Topological polar surface area
- 101 Ų
- Hydrogen bond donors
- 2
- Hydrogen bond acceptors
- 6
- Rotatable bonds
- 8
- Heavy atoms
- 23
- Formal charge
- 0
- Complexity
- 459
Physicochemical properties
- Boiling point
- 551.7 · 551.7±60.0 °C(Predicted)
- Density
- 1.328 · 1.328±0.06 g/cm3(Predicted)
- form
- Solid
- pka
- 3.19 · 3.19±0.10(Predicted)
- FDA UNII
- 74574 CO5A6 · 74574CO5A6
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
Applications
UsesGlomerulonephritis treatment.
Suppliers6 total
Hangzhou Sage Chemical Co., Ltd.+86057186818502 13588463833 · [email protected]
上海寰川实业有限公司021-61478794 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
TargetMol中国（陶术生物）15002134094 · [email protected]
上海阿摩尔生物科技有限公司13370042665 18916960931 · [email protected]
Related reactions
2 records
Compound notes
Loading…